Retina/Vitreous

Top Story

GenSight’s LHON treatment receives French temporary authorization for use

December 10, 2019

Study to focus on microgravity’s effect on microcirculation

December 6, 2019
A research study evaluating the effects microgravity has on the central microcirculation of the bodies of astronauts and jet pilots will begin in 2020, funded by the…

Foundation Fighting Blindness launches retinitis pigmentosa natural history study

December 5, 2019
A natural history study for people with retinitis pigmentosa caused by mutations in the gene EYS has been launched by the Foundation Fighting Blindness. The 4-year…

Benelux countries approve Iluvien for noninfectious posterior uveitis

December 4, 2019
Iluvien has been approved by the governmental agencies overseeing medical products in Belgium, the Netherlands and Luxemburg, Alimera Sciences announced in a press…
More Headlines »
Clinical Science Imaging

Noninvasive Imaging of Mitochondrial Dysfunction in Dry Age-Related Macular Degeneration

Ophthalmic Surgery, Lasers and Imaging Retina, September 2012, Volume 43 Issue 5
Oxidative stress and mitochondrial dysfunction are implicated in the pathogenesis of age-related macular degeneration…
More »
CME

Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration—An Eye Toward the Future: What Is on the Horizon in nAMD?

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care…
More »
Video
Meeting News

VIDEO: Novel oral therapy drug safe, effective for wet AMD

November 21, 2019
More »
From OSN Europe

GenSight’s LHON treatment receives French temporary authorization for use

December 10, 2019
A patient at France’s National Eye Hospital of the Quinze-Vingts has been granted temporary authorization for use of Lumevoq, GenSight…

Study to focus on microgravity’s effect on microcirculation

December 6, 2019
A research study evaluating the effects microgravity has on the central microcirculation of the bodies of astronauts and jet pilots will begin in…

Foundation Fighting Blindness launches retinitis pigmentosa natural history study

December 5, 2019
A natural history study for people with retinitis pigmentosa caused by mutations in the gene EYS has been launched by the Foundation Fighting…

Benelux countries approve Iluvien for noninfectious posterior uveitis

December 4, 2019
Iluvien has been approved by the governmental agencies overseeing medical products in Belgium, the Netherlands and Luxemburg, Alimera Sciences…

J-code activations simplify billing reimbursements for practices

December 3, 2019
Several CMS-designated permanent and product-specific J-codes recently went into effect, allowing three ophthalmology-minded pharmaceutical companies…

Meeting News

Gene therapy reduces treatment burden, improves vision in wet AMD

November 25, 2019
SAN FRANCISCO — RGX-314 gene therapy demonstrated meaningful reductions in anti-VEGF injections and increases in visual acuity and central…

In the Journals

Use of mask after ROP exam helps minimize stress in infants

November 22, 2019
Using a mask to decrease photosensitivity following screening for retinopathy of prematurity reduced stress in the infants after the examination…

ProQR’s retinitis pigmentosa treatment gets orphan drug designation

November 21, 2019
QR-1123, a first-in-class investigational antisense oligonucleotide for the treatment of vision loss associated with autosomal dominant retinitis…

Meeting NewsVideo

VIDEO: Novel oral therapy drug safe, effective for wet AMD

November 21, 2019
SAN FRANCISCO —Twice daily dosing of oral AKST4290 over the course of 6 weeks improved visual acuity in patients with neovascular age-related…

Meeting NewsVideo

VIDEO: AI, deep learning rapidly evolving to real-world applications in diagnosing retinal disease

November 19, 2019
NEW YORK — At OSN New York 2019, Darius Moshfeghi, MD, discusses the progress being made around the world in research into artificial…

Meeting News

Patients with AMD can successfully self-operate OCT device at home

November 19, 2019
SAN FRANCISCO — Patients with age-related macular degeneration could successfully self-operate an optical coherence tomography device at home…

Home monitoring systems, longer-acting drugs should ease burden of retinal disease

Ocular Surgery News U.S. Edition, November 25, 2019
New longer-acting molecules and home monitoring will soon help relieve the increasing burden of age-related macular degeneration and diabetes-related…

Meeting News

Luminate shows potential in dry AMD

November 15, 2019
SAN FRANCISCO — Risuteganib showed potential for the treatment of intermediate dry age-related macular degeneration, according to study results…

Chocolate study leads October retina news

November 14, 2019
Retina-related news on Healio/OSN in October included an FDA approval, study results and meeting news coverage. Here are the top five most-read…

Meeting News

Test combining fundus, OCT imaging improves AMD diagnosis

November 13, 2019
SAN FRANCISCO — A screening strategy combining fundus and OCT imaging improved the accuracy of age-related macular degeneration classification…

Blog

BLOG: Gene therapy promising for treatment of neovascular AMD

November 12, 2019
This year’s American Academy of Ophthalmology meeting in San Francisco had significant data releases from pharmaceutical companies focused on…

Meeting NewsVideo

VIDEO: Gene therapy for wet AMD ‘on the horizon’

November 11, 2019
SAN FRANCISCO — In the OPTIC trial, patients with wet age-related macular degeneration who were treated with ADVM-022, an intravitreal gene…

Cedars-Sinai receives $10.5 million to study RP stem cell treatment

November 8, 2019
Cedars-Sinai researchers have received a $10.5 million grant from the California Institute for Regenerative Medicine to launch a clinical trial…

$17.2 million grant awarded to research Alzheimer’s connection with eye health

November 7, 2019
The National Institute on Aging has awarded a $17.2 million grant to University of Washington School of Medicine assistant professor of ophthalmology…

Meeting News

OpRegen subretinal transplantation appears well-tolerated in dry AMD

November 7, 2019
SAN FRANCISCO — OpRegen, a human embryonic stem cell-derived retinal pigment epithelial cell therapy transplanted subretinally, appeared…

More Headlines »